Proposed clinical trials involving human gene transfer require registration and approval from both campus and federal agencies before initiation. The Yale University Institutional Biological Safety Committee requirements for human gene therapy protocols are detailed in the Guidelines for Human Gene Transfer Clinical Trials. Learn more at the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.
Training
- Bloodborne Pathogens Awareness Program (PRG-FL-EHS-018)
- Bloodborne Pathogens for Clinical Employees (PRG-SRPR-EHS-024)
- Bloodborne Pathogens for Clinical Visitors (PRG-SRPR-EHS-025)
- Bloodborne Pathogens for Custodial Personnel (PRG-SRPR-EHS-029)
- Bloodborne Pathogens for Facilities Personnel (PRG-SRPR-EHS-030)
- Bloodborne Pathogens for Lab Employees
(PRG-SRPR-EHS-011) - Bloodborne Pathogens for Lab Students
(PRG-SRPR-EHS-028) - Bloodborne Pathogens for Lab Visitors
(PRG-SRPR-EHS-027) - Bloodborne Pathogens for Clinical Yale Students
(PRG-SRPR-EHS-026) - Bloodborne Pathogens Self Study
(SRPR-EHS-076)
All Biological Safety Training
Forms
- Human Gene Transfer Registration
- Recombinant DNA or Synthetic Nucleic Acid Molecules Registration
All Biological Safety Forms